| Sl No |
Particulars |
| 1. |
P S Roy, S John, S Kannan, N Khattry, S Gujral, M Sengar, H Menon, R Nair. Comparison of Efficacy and Safety of Rituximab (MabtheraTM) And its Biosimilar (RedituxTM) in diffuse Large B-cell Lymphoma (DLBCL) Patients Treated with Chemo-Immunotherapy: A Retrospective Analysis. Indian Journal of Medical and Paediatric Oncology ; 34(4), 2013, p29 –298. |
| 2. |
M Hazarika, C Bhuyan, B J Saikia, P S Roy. Overview of Childhood Cancers at a Regional Cancer Centre in North-East India.” Asian Pac J Cancer Prev , 15(18), 2014, p7817–7819. |
| 3. |
M Hazarika, C Bhyuan, B J Saikia, A Ahmed, P S Roy. Adult Non-Hodgkins Lymphoma patients: Experience from a Tertiary Care Cancer Centre in North-East India.” Asian Pac J Cancer Prev . Vol 16(7), 2015, p2879-2881 |
| 4. |
P S Roy, B J Saikia. Cancer and Cure: A Critical Analysis. Indian J Cancer 2016; 53: p441-2. |
| 5. |
P S Roy, AInamdar, T. Nyodu, M Hazarika. Physical Factors of Carcinogenesis Assam Journal of Internal Medicine, July 2017, Vol 7, Issue 2, p29-32. |
| 6. |
P S Roy, T Nyodu, M Hazarika. Prevalence of HER2 Expression and its Correlatioon with Clinicopathological Parameters in Gastric or Gastroexophageal Junction Adenocarcinoma in North-East Indian Population. Asian Pac J Cancer Prev. Vol 20 (4), 1139-45. |
| 7. |
M Hazariaka, Rakesh Mishra, P S Roy. Causes of Treatment Abandonment of Pediatric Cancer Patients – Experience in a Regional Cancer Centre in North East India. Asian Pac J Cancer Prev . Vol 20 (4), 1133-37. |
| 8. |
A Sarma, A K Rai, P S Roy.Association of ABL kinase domain T315I mutation with Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia Patients of North-East India. Vol I. Issue XCVIX, May 2019; 27-35. |
